The Current Ratio as of December 2024 (TTM) for Sonoma Pharmaceuticals, Inc. (SNOA) is 3.69

According to Sonoma Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.69. This represents a change of 4.18% compared to the average of 3.55 of the last 4 quarters.

Sonoma Pharmaceuticals, Inc. (SNOA) Historical Current Ratio (quarterly & annually)

How has SNOA Current Ratio performed in the past?

The mean historical Current Ratio of Sonoma Pharmaceuticals, Inc. over the last ten years is 3.84. The current 3.69 Current Ratio has changed 9.53% with respect to the historical average. Over the past ten years (40 quarters), SNOA's Current Ratio was at its highest in in the March 2017 quarter at 6.89. The Current Ratio was at its lowest in in the December 2014 quarter at 1.48.

Sonoma Pharmaceuticals, Inc. (SNOA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Sonoma Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sonoma Pharmaceuticals, Inc. (SNOA) Average Current Ratio

How has SNOA Current Ratio performed in the past?

The current Current Ratio of Sonoma Pharmaceuticals, Inc. (SNOA) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Sonoma Pharmaceuticals, Inc. (SNOA) Current Ratio vs. Peers

How is SNOA’s Current Ratio compared to its peers?

Sonoma Pharmaceuticals, Inc.’s Current Ratio is greater than China Pharma Holdings, Inc. (0.79), greater than Universe Pharmaceuticals INC (1.63), greater than Acorda Therapeutics, Inc. (0.22), greater than Akanda Corp. (1.41), greater than Petros Pharmaceuticals, Inc. (0.85), less than Sunshine Biopharma, Inc. (5.74), less than Guardion Health Sciences, Inc. (16.67), less than Alpha Teknova, Inc. (4.73), greater than Cannara Biotech Inc. (2.50), greater than MC Endeavors, Inc. (0.01), greater than Unrivaled Brands, Inc. (0.12), greater than GelStat Corporation (0.06), less than Shionogi & Co., Ltd. (7.07), greater than Alimera Sciences, Inc. (2.79), greater than China SXT Pharmaceuticals, Inc. (1.60), greater than Shuttle Pharmaceuticals Holdings, Inc. (0.22), greater than Lifecore Biomedical, Inc. (1.83), greater than Mallinckrodt plc (2.74), greater than Journey Medical Corporation (1.38),

Build a custom stock screener for Sonoma Pharmaceuticals, Inc. (SNOA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sonoma Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sonoma Pharmaceuticals, Inc. (SNOA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sonoma Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.